Basic Information
Ceptur Therapeutics, Inc. is a preclinical-stage biotechnology company focused on developing targeted oligonucleotide therapies based on U1 Adapter technology. The company is developing unique and differentiated genetic medicines for patients with unmet diseases.
Ceptur Therapeutics, Inc.
NewJersey,United States of America
less than 15 people
January 01, 2008
contactus@cepturtx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios